Another concern is the heterogeneous nature of tumor, that may affect the PD-L1 quantification depending on the origin of the biopsy (primary tumor or metastasis), the degree of intratumoral heterogeneity and the sampling methodology (biopsy or tumor resection) [22]. The gene discussed is CD274; the disease is neoplasm.